Catalyst Funds Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,400
Closed -$65.4K 1515
2024
Q1
$65.4K Buy
+1,400
New +$65.4K 0.02% 494